Health technology company Royal Philips and Mullica Hill-based Inspira Health announced on Monday a strategic five-year partnership agreement worth $50 million to standardize patient monitoring and drive innovation in diagnostic imaging solutions to enhance patient care and improve clinical workflow performance.
The companies announced the new partnership at the Radiological Society of North America’s 2019 Annual Meeting which is taking place Dec. 1 – Dec. 6 in Chicago.
The partnership will make Andover, Mass.-based Philips solutions available to more than a dozen Inspira health facilities. The contract also includes training and services that will maximize Inspira’s operational efficiency. It will allow Inspira to standardize diagnostic imaging and patient monitoring technologies across the network, making data more integrated and allowing clinicians access to the right patient data, which will facilitate better diagnosis and treatment.
According to Inspira, long-term strategic partnerships (LSPs) are a growing trend used within hospitals and health systems to better manage the cost and complexity of technology investments over a defined period, while expanding quality access to advanced medical care in order to improve patient outcomes.
Philips will provide Inspira with the latest in diagnostic imaging solutions, patient care monitoring systems, and minimally invasive solutions such as the Philips Azurion image-guided therapy platform.
“At Inspira, we are focused on leveraging technology that enables our teams to provide the best possible care. By working closely with Philips, we have an opportunity to stay at the cutting edge of imaging and patient monitoring,” said John DiAngelo, president and chief executive officer of Inspira Health. “This partnership will bring countless benefits to our patients, physicians and clinical teams. It comes down to ensuring that each individual community within our broader community is taken care of,” DiAngelo said.
Driven by benefits for patients and care providers, minimally invasive therapies such as the catheter-based treatment of certain tumors, aneurysms, obstructed blood vessels, heart rhythm disorders and defective heart valves continue to grow fast. These therapies are also more cost-effective and support Inspira’s vision of providing quality care for its communities, with a focus on cancer and cardiac care.
Inspira delivers a full continuum of primary, acute and advanced care services. The health system is comprised of three hospitals, a comprehensive cancer center, several multi-specialty health centers and a total of more than 150 access points. The health network is also opening a state-of-the-art hospital this month and an adjacent leading-edge cancer center in January in Mullica Hill. Both will incorporate Philips technology to create an integrated care facility centered on patient needs.